TREATMENT OF LEPTOMENINGEAL METASTASIS FROM NON-SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS

被引：0
|
作者：
Nanjo, S. [1 ]
Katakami, N. [2 ]
Otsuka, K. [1 ]
Tachikawa, R. [1 ]
Hata, A. [2 ]
Otsuka, K. [1 ]
Kaji, R. [2 ]
Fujita, S. [3 ]
Hayashi, M. [1 ]
Tomii, K. [1 ]
机构：
[1] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan
[2] Inst Biomed Res & Innovat, Div Integrated Oncol, Kobe, Hyogo, Japan
[3] Inst Biomed Res & Innovat, Dept Translat Res, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [21] Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis.
    Liao, Bin-Chi
    Lee, Jih-hsiang
    Lin, Chia-Chi
    Ho, Chao-Chi
    Shih, Jin-Yuan
    Yu, Chong-Jen
    Yang, James Chih-Hsin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer
    Zhang, Jingze
    Yu, Jinming
    Sun, Xindong
    Meng, Xue
    CANCER LETTERS, 2014, 351 (01) : 6 - 12
  • [23] EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS IN TREATMENT OF NON-SMALL CELL LUNG CANCER
    Kilickap, Saadettin
    NOBEL MEDICUS, 2018, 14 (03): : 5 - 8
  • [24] Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Sequist, Lecia V.
    ONCOLOGIST, 2007, 12 (03): : 325 - 330
  • [25] Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Engelman, Jeffrey A.
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (10) : 2895 - 2899
  • [26] Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
    Riely, Gregory J.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : S146 - S149
  • [27] Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
    Tan, Chee-Seng
    Cho, Byoung-Chul
    Soo, Ross A.
    LUNG CANCER, 2016, 93 : 59 - 68
  • [28] Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment
    Schettino, Clorinda
    Bareschino, Maria Anna
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 226 - 235
  • [29] Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
    Jaenne, Pasi A.
    Johnson, Bruce E.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4416S - 4420S
  • [30] A COMPARATIVE STUDY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN TREATMENT OF PATIENTS WITH BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER
    Zhang, L.
    Cai, L.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 421 - 421
12345